71 related articles for article (PubMed ID: 18315894)
1. [Polymorphisms of CYP3A5 gene in acute leukemia patients and their role in chemotherapy and prognosis].
Shen LJ; Chen FY; Wang T; Wang HR; Zhong JH; Han JY; Ouyang RR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):26-30. PubMed ID: 18315894
[TBL] [Abstract][Full Text] [Related]
2. [Expression of CYP3A5 mRNA in children with acute leukemia].
Huang Z; Chai YH; Cen JN; He HL; Li J
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):549-54. PubMed ID: 19650988
[TBL] [Abstract][Full Text] [Related]
3. Analysis of CYP3A5*3 and CYP3A5*6 gene polymorphisms in Indian chronic myeloid leukemia patients.
Sailaja K; Rao DN; Rao DR; Vishnupriya S
Asian Pac J Cancer Prev; 2010; 11(3):781-4. PubMed ID: 21039054
[TBL] [Abstract][Full Text] [Related]
4. Effects of cytochrome P450 family 3 subfamily A member 5 gene polymorphisms on daunorubicin metabolism and adverse reactions in patients with acute leukemia.
Huang Z; Wang J; Qian J; Li Y; Xu Z; Chen M; Tong H
Mol Med Rep; 2017 Jun; 15(6):3493-3498. PubMed ID: 28440407
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism analysis of CYP3A5 in myeloid leukemia.
Liu TC; Lin SF; Chen TP; Chang JG
Oncol Rep; 2002; 9(2):327-9. PubMed ID: 11836601
[TBL] [Abstract][Full Text] [Related]
6. Do SLCO1B3 (T334G) and CYP3A5*3 polymorphisms affect response in Egyptian chronic myeloid leukemia patients receiving imatinib therapy?
Bedewy AM; El-Maghraby SM
Hematology; 2013 Jul; 18(4):211-6. PubMed ID: 23394475
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphism of CYP3A5 in Indian chronic myeloid leukemia patients.
Bajpai P; Tripathi AK; Agrawal D
Mol Cell Biochem; 2010 Mar; 336(1-2):49-54. PubMed ID: 19823770
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism of the CYP3A5 gene and its effect on tacrolimus blood level.
Nair SS; Sarasamma S; Gracious N; George J; Anish TS; Radhakrishnan R
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():197-200. PubMed ID: 25894154
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of the CYP3A4, CYP3A5, CYP3A7 and CYP1A2 among the Jordanian population.
Salameh G; Al Hadidi K; El Khateeb M
Environ Toxicol Pharmacol; 2012 Jul; 34(1):23-33. PubMed ID: 22426036
[TBL] [Abstract][Full Text] [Related]
10. CYP3A5*3 and MDR-1 C3435T single nucleotide polymorphisms in six Chinese ethnic groups.
Lai Y; Zhang J; Wang YX; Wang XD; Li JL; Wang YH; Zeng YJ; Huang M
Pharmazie; 2011 Feb; 66(2):136-40. PubMed ID: 21434577
[TBL] [Abstract][Full Text] [Related]
11. [Study on polymorphisms of CYP3A5 gene and their clinical role].
Wang HP; Xie JJ; Zhang ZY; Ying Y; Zhu ZG; Mao P
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):423-6. PubMed ID: 16086282
[TBL] [Abstract][Full Text] [Related]
12. The genetic polymorphisms of POR*28 and CYP3A5*3 significantly influence the pharmacokinetics of tacrolimus in Chinese renal transplant recipients.
Zhang JJ; Liu SB; Xue L; Ding XL; Zhang H; Miao LY
Int J Clin Pharmacol Ther; 2015 Sep; 53(9):728-36. PubMed ID: 26227094
[TBL] [Abstract][Full Text] [Related]
13. Influence of CYP3A5 genetic polymorphism on tacrolimus daily dose requirements and acute rejection in renal graft recipients.
Quteineh L; Verstuyft C; Furlan V; Durrbach A; Letierce A; Ferlicot S; Taburet AM; Charpentier B; Becquemont L
Basic Clin Pharmacol Toxicol; 2008 Dec; 103(6):546-52. PubMed ID: 19067682
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in CYP2C8 and CYP3A5 genes in the Nigerian population.
Adehin A; Bolaji OO; Kennedy MA
Drug Metab Pharmacokinet; 2017 Jun; 32(3):189-191. PubMed ID: 28427759
[TBL] [Abstract][Full Text] [Related]
15. Influence of CYP3A5 and ABCB1 gene polymorphisms on calcineurin inhibitor-related neurotoxicity after hematopoietic stem cell transplantation.
Yanagimachi M; Naruto T; Tanoshima R; Kato H; Yokosuka T; Kajiwara R; Fujii H; Tanaka F; Goto H; Yagihashi T; Kosaki K; Yokota S
Clin Transplant; 2010; 24(6):855-61. PubMed ID: 20030680
[TBL] [Abstract][Full Text] [Related]
16. Genetic association in
Bellah SF; Salam MA; Billah SMS; Karim MR
Ann Hum Biol; 2023 Feb; 50(1):63-74. PubMed ID: 36688864
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus dosing in adult lung transplant patients is related to cytochrome P4503A5 gene polymorphism.
Zheng H; Zeevi A; Schuetz E; Lamba J; McCurry K; Griffith BP; Webber S; Ristich J; Dauber J; Iacono A; Grgurich W; Zaldonis D; McDade K; Zhang J; Burckart GJ
J Clin Pharmacol; 2004 Feb; 44(2):135-40. PubMed ID: 14747421
[TBL] [Abstract][Full Text] [Related]
18. The role of CYP3A5 genotypes in dose requirements of tacrolimus and everolimus after heart transplantation.
Kniepeiss D; Renner W; Trummer O; Wagner D; Wasler A; Khoschsorur GA; Truschnig-Wilders M; Tscheliessnigg KH
Clin Transplant; 2011; 25(1):146-50. PubMed ID: 20041908
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between the CYP3A5 genetic polymorphism and susceptibility to and prognosis of childhood acute leukemia].
Huang Z; Chai YH; Cen JN
Zhonghua Er Ke Za Zhi; 2007 Jul; 45(7):546-8. PubMed ID: 17953817
[No Abstract] [Full Text] [Related]
20. Influence of CYP3A5 and MDR1 genetic polymorphisms on urinary 6 beta-hydroxycortisol/cortisol ratio after grapefruit juice intake in healthy Chinese.
Li D; Abudula A; Abulahake M; Zhu AP; Lou YQ; Zhang GL
J Clin Pharmacol; 2010 Jul; 50(7):775-84. PubMed ID: 20160155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
